Nuwellis (NUWE) FCF Margin Growth (1y) (2014 - 2026)
Nuwellis (NUWE) FCF Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | -1,716.00 |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 2,833.00 |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | -125.00 |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 2,811.00 |
| 10 | Nuwellis | 112,643.40 | -1.97 Mn | 1.68 Mn | 244.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 244.00 |
| Dec 31, 2025 | -5,874.00 |
| Sep 30, 2025 | -4,265.00 |
| Jun 30, 2025 | 482.00 |
| Mar 31, 2025 | 2,249.00 |
| Dec 31, 2024 | 4,078.00 |
| Sep 30, 2024 | 5,988.00 |
| Jun 30, 2024 | 12,895.00 |
| Mar 31, 2024 | 17,942.00 |
| Dec 31, 2023 | 2,796.00 |
| Sep 30, 2023 | -481.00 |
| Jun 30, 2023 | -7,712.00 |
| Mar 31, 2023 | -8,085.00 |
| Dec 31, 2022 | 12,025.00 |
| Sep 30, 2022 | 8,622.00 |
| Jun 30, 2022 | -2,290.00 |
| Mar 31, 2022 | 2,927.00 |
| Dec 31, 2021 | -8,352.00 |
| Sep 30, 2021 | -651.00 |
| Jun 30, 2021 | 2,250.00 |